Atropos Health Raises $33M To Scale The Automation Of High-Quality, Personalized Real-World Evidence Leveraging Generative AI
On Thursday, May 23, real-world data healthcare technology company Atropos Health announced that it had secured a $33 million Series B financing round, in light of the recent adoption of the company’s GENEVA OS™ platform, which is now being used by a variety of medical practices and researchers across the healthcare industry. The Series B financing was led by WCAS portfolio company Valtruis, as well as other investors including Cencora Ventures, McKesson Ventures, Merck Global Health Innovation Fund, and more. With this funding, Atropos is...